GTCR PARTNERS XI/A&C LP
SEC CIK 1828028 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SHC | Sotera Health Co | Dir, 10% | 49.22M | — | $308.61M | 2 | 2024-03-04 | 2024-09-06 |
Most active insiders at SHC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | WARBURG PINCUS & CO. | Dir, 10% | — | $579.51M |
| 2 | Warburg Pincus Partners II, L.P. | Dir, 10% | — | $510.75M |
| 3 | Warburg Pincus Partners GP LLC | Dir, 10% | — | $387.78M |
| 4 | GTCR FUND XI/A LP | Dir, 10% | — | $293.62M |
| 5 | Warburg Pincus Private Equity XI-C, L.P. | Dir, 10% | — | $281.70M |
| 6 | GTCR INVESTMENT XI LLC | Dir, 10% | — | $193.17M |
| 7 | WARBURG PINCUS LLC | Dir, 10% | — | $158.73M |
| 8 | GTCR CO-INVEST XI LP | Dir, 10% | — | $152.70M |
| 9 | Petras Michael B. Jr. | Executive COB, Dir | — | $33.51M |
| 10 | Rutz Michael P | Pres of Sterigenics | — | $2.83M |
GTCR PARTNERS XI/A&C LP made no open-market trades at SHC in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-09-09 | 2024-09-06 | SHC | Sotera Health Co | GTCR PARTNERS XI/A&C LP | Dir, 10% | S - Sale | $15.03 | -10.00M | 49.22M | -17% | -$150.30M |
| I | 2024-03-06 | 2024-03-04 | SHC | Sotera Health Co | GTCR PARTNERS XI/A&C LP | Dir, 10% | S - Sale | $14.31 | -11.06M | 59.22M | -16% | -$158.31M |
Purchase Sale Sale after option exercise All abbreviations